Based on the company's latest reports for June 2026, the current 12-month EPS is $0.85. Omnicell's earnings per share in 2025 was reported at $0.04, marking a decrease from $0.27 in 2024. In the quarterly report ending on Jun 30, 2026, OMCL's earnings per share amounted to $0.53.
Omnicell had an yealy earnings per share of $0.04, showing a decrease of 85.2% from $0.27 recorded in 2024. The quarterly earnings per share for the period ending Jun 30, 2026, was $0.53, showing a 341.7% increase compared to the same quarter last year. The trailing twelve months EPS for OMCL is $0.85 as of June 2026. Omnicell's full-year EPS for 2024 was $0.27, a 160% rise compared to the previous year.
Over the past 12 months, Omnicell has recorded an earnings per share growth rate of 341.7% (YoY, quarterly). Over an extended period, the company recorded an average EPS annual growth rate of -32.5% per year for the last 3 years. In the last five years, the company had an average annual EPS growth of -44.5%. A ten-year view shows that OMCL has seen an average earnings per share growth of -26.4% per year.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| MCK Mckesson Corporation | 23.5 | 49.1% | 15.2% | N/A |
| STE Steris Plc | 25.58 | 27.7% | 95.3% | 11.3% |
| CAH Cardinal Health Inc | 30.44 | 12.2% | 78.9% | 28.3% |
| OMCL Omnicell Inc | 38.81 | -85.2% | -32.5% | -44.5% |
All data is based on quarterly TTM periods, unless otherwise specified.